{
    "2018-03-21": [
        [
            {
                "time": "2018-03-21",
                "original_text": "明日最具投资机会六大牛股一览（3月21日）",
                "features": {
                    "keywords": [
                        "投资机会",
                        "牛股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "[看好评级] 生物制品行业周报：复星、石药等32家公司入选“中国生物医药指数”",
                "features": {
                    "keywords": [
                        "生物医药指数",
                        "复星",
                        "石药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "[买入-A评级] 智飞生物(300122)年报点评：代理自产齐放量 业绩维持高增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "[强烈推荐评级] 智飞生物(300122)年报点评：2018Q1延续高速增长 五价轮状疫苗获批在即",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "五价轮状疫苗"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "券商首次关注7股并给予买入评级(3月21日)",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "医药行业：科技创新才是医药行业发展主驱动力",
                "features": {
                    "keywords": [
                        "医药行业",
                        "科技创新"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "[买入评级] 智飞生物(300122)：疫苗之王 业绩爆发超预期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "疫苗",
                        "业绩爆发"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "被全民唾弃堕入深渊 而今净利润暴涨超12倍 它是如何逆袭的",
                "features": {
                    "keywords": [
                        "净利润",
                        "暴涨",
                        "逆袭"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "【天风Morning Call】晨会集萃20180321",
                "features": {
                    "keywords": [
                        "晨会",
                        "集萃"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "【浙商医药】行业点评：行业拐点元年，创新提速，强者恒强",
                "features": {
                    "keywords": [
                        "医药",
                        "行业拐点",
                        "创新提速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}